UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.

vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment for Early Tooth Decay – Biotech Investments

EQS-News: vVardis AG / Key word(s): Financing vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment

February 12, 2025

Former Seagen CEO David Epstein to lead new biotech with VEGF bifunctional antibody

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 29, 2024

Generative AI-focused biotech startup Evozyne raises $81m – Pharmaceutical Technology

Generative AI is being touted as a transformer of the drug discovery process, with benefits including reducing the time to market for new drugs, lowering

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.